The G protein-coupled receptor TBXA2R activates ERMs to promote motility, invasion, and metastasis of triple-negative breast cancer cells
Preprint in bioRxiv (March 2023)
The most recent citing publications are shown below. View all 172 publications that cite this research output on Dimensions.
Perspectives for Targeting Ezrin in Cancer Development and Progression
Article in Future Pharmacology (January 2023)
Targeting the ezrin adaptor protein sensitizes metastatic breast cancer cells to chemotherapy and reduces neoadjuvant therapy-induced metastasis
Article in Cancer Research Communications (June 2022)